Editorial
Published in:
Transfuze Hematol. dnes,30, 2024, No. 1, p. 3.
Category:
Editorial
Labels
Haematology Internal medicine Clinical oncologyArticle was published in
Transfusion and Haematology Today
2024 Issue 1
- Cost Effectiveness of FVIII Substitution Versus Non-Factor Therapy for Hemophilia A
- Vascular Disease in the Gradually Aging Population of Hemophiliacs: An Underestimated Problem?
- Prognostic Significance of Subclinical Joint Changes on MRI in Hemophilia
- Immunotolerance is still the goal of management of hemophilia A with inhibitor in the era of non-factor therapy
- Minimum and Optimal Factor Levels in Physically Active Hemophiliacs
Most read in this issue
- Therapy targeting CD19 antigen in diffuse large B-cell lymphoma
- Descriptive epidemiology of selected haemato-oncological diseases in the Czech Republic
- Artificial intelligence in bone marrow cytomorphology: Morphogo and Scopio
- Primary multifocal extramedullary multiple myeloma with a rare cytogentic abnormality